SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Pacific Biosciences Q1 EPS $0.010 May Not Compare To $(0.160) Estimate, Sales $15.598M Miss $20.070M Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly earnings of $0.010 per share which beat the analyst consensus estimate of $(0.160) by 106.25 percent. This is a 105 percent increase over losses of $(0.200) per share

Benzinga · 05/06/2020 20:33

Pacific Biosciences (NASDAQ:PACB) reported quarterly earnings of $0.010 per share which beat the analyst consensus estimate of $(0.160) by 106.25 percent. This is a 105 percent increase over losses of $(0.200) per share from the same period last year. The company reported quarterly sales of $15.598 million which missed the analyst consensus estimate of $20.070 million by 22.28 percent. This is a 5.04 percent decrease over sales of $16.425 million the same period last year.